AdvanCell
Biotechnology company with a recent SEC Form D offering.
Biotech
📍 CAMBRIDGE, MASSACHUSETTS
Current Valuation
Private
PRIVATE
Biotechnology company headquartered in CAMBRIDGE, MASSACHUSETTS. Filed SEC Form D on 20260716 for a $218.3M Regulation D offering.
Company Profile
HQ
CAMBRIDGE, MASSACHUSETTS
Growth
Filed SEC Form D on 20260716 for $218.3M Regulation D offering
Last Round
Form D filing — $218M (Invalid Date)
Fundraising Status
Form D filing · $218M
privateTotal raised $218M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $218M | Invalid Date | — | — |
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.